Axovant reports 3-month data on patient with infantile Tay-Sachs disease treated with AXO-AAV-GM2 March 12, 2019
Steroidogenic 17beta-HSD2 inhibition for targeted intracrine therapy in bone fracture healing March 12, 2019
Extended evaluation phase findings from SONICS study of Recorlev in endogenous Cushing's syndrome March 12, 2019
RSS